Dark

Check out our Level2View

PROG
Biora Therapeutics, Inc. Common Stock
stock NASDAQ

Inactive

May 6, 2022

0.8845USD-3.470%(-0.0318)2,779,613

Pre-market

0.00USD-100.000%(-0.92)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 25, 2022

04:05PM EST Progenity Strengthens Intellectual Property for Single-Molecule GlobeNewswire Inc

Jan 11, 2022

06:30AM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that patient data on indicators of efficacy in the treatment of gastrointestinal disorders has been accepted for oral presentation during the 34th edition of the Belgian Week of Gastroenterology, February 9-11, 2022. GlobeNewswire Inc

Jan 5, 2022

06:32AM EST Progenity Announces Acceptance Of Two Abstracts On Treatment Of Gastrointestinal Disorders At ECCO'22 Benzinga

06:30AM EST Progenity Announces Acceptance of Two Abstracts on Treatment of GlobeNewswire Inc

Jan 3, 2022

06:30AM EST Progenity to Participate in the H.C. GlobeNewswire Inc

Dec 20, 2021

04:05PM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced it has successfully closed the business divestiture of its affiliate Avero Diagnostics through an asset sale to Northwest Pathology. GlobeNewswire Inc

Dec 2, 2021

06:34AM EST Progenity Announces New Patent For Single-Molecule Detection Technology Benzinga

06:30AM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection platform under development. GlobeNewswire Inc

Nov 30, 2021

04:44PM EST Progenity Granted U.S. Patent #11,186,863 'Methods, systems, and compositions for counting nucleic acid molecules' Benzinga

Nov 23, 2021

06:42AM EST Progenity Says Received More Than $44M In Warrant Exercises Since August 2021 Benzinga

06:30AM EST Company received more than $44 million in warrant exercises since August 2021. GlobeNewswire Inc

Nov 18, 2021

07:55AM EST The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings Benzinga

Nov 17, 2021

06:59AM EST Top 10 WallStreetBets Mentions in Premarket Session for November 17: LCID, GOEV, TSLA, GME, ATVI, NVDA, RBLX, PROG, SNDL, AMC Benzinga

05:29AM EST Rivian Overtakes Tesla As Top WallStreetBets Interest; Lucid, Nvidia And These Are Other Top Trends Today Benzinga

Nov 16, 2021

10:21AM EST Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations Benzinga

Nov 15, 2021

06:30AM EST Progenity to Participate in the Piper Sandler GlobeNewswire Inc

Nov 11, 2021

08:03AM EST The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts Benzinga

Nov 10, 2021

04:50PM EST Progenity Q3 EPS $(0.46) Misses $(0.45) Estimate Benzinga

04:01PM EST Added important patents further protecting the companys therapeutic delivery technologies GlobeNewswire Inc

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Nov 9, 2021

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:28AM EST Progenity Appoints Adi Mohanty As Chief Executive Officer Benzinga

06:30AM EST Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the company, effective November 8, 2021. Mr. Mohanty also joins the Progenity Board of Directors. GlobeNewswire Inc

Nov 4, 2021

06:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November 3, 2021. Ms. Howe was also appointed chairperson of the Audit Committee and member of the Nominating and Corporate Governance Committee. GlobeNewswire Inc

Nov 3, 2021

07:30AM EDT Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report third quarter 2021 financial results on Wednesday, November 10, 2021 after the close of financial markets. Progenitys management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update. GlobeNewswire Inc

Oct 27, 2021

10:06AM EDT Progenity Option Alert: Nov 19 $4.5 Calls Sweep (8) near the Ask: 225 @ $1.151 vs 14674 OI; Earnings 11/8 After Close [est] Ref=$4.3102 Benzinga

Oct 26, 2021

07:33AM EDT Progenity Cuts Outstanding Debt By $20.175M Through Private Exchange Of Its 7.25% Convertible Senior Notes Due 2025 For Common Stock Benzinga

07:30AM EDT Progenity Reduces Outstanding Debt by $20.175 Million Through a GlobeNewswire Inc

Oct 19, 2021

10:08AM EDT Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance Benzinga

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate Product Development for Crohns & Colitis virtual conference, hosted by the Crohns & Colitis Foundation, November 18-19, 2021. GlobeNewswire Inc

Oct 18, 2021

01:15PM EDT Progenity Option Alert: Nov 19 $3 Calls Sweep (4) near the Ask: 468 @ $0.65 vs 16043 OI; Earnings 11/8 After Close [est] Ref=$2.81 Benzinga

Oct 14, 2021

11:18AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 Benzinga

06:21AM EDT HC Wainwright & Co. Initiates Coverage On Progenity with Buy Rating, Announces Price Target of $4 Benzinga

Oct 13, 2021

01:38PM EDT Progenity Announces Multiple Patents Granted By USPTO Benzinga

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued four patents related to its ingestible technologies for delivery of therapeutics via the gastrointestinal (GI) tract. GlobeNewswire Inc

Oct 12, 2021

05:47AM EDT The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.30 A.M. EDT). RTTNews

Oct 7, 2021

06:30AM EDT The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.05 A.M. EDT). RTTNews

Oct 6, 2021

04:02PM EDT Progenity Announces Closing of $20 Million Registered Direct GlobeNewswire Inc

Oct 5, 2021

09:17AM EDT Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Oct. 5, 2021: RIDE, RL, CCXI, ANVS, PROG Benzinga

Oct 4, 2021

01:41PM EDT Progenity Reports 13.33M Share At The Market Offering At $1.50/Share Benzinga

01:40PM EDT Progenity Announces $20 Million Registered Direct Offering of GlobeNewswire Inc

01:34PM EDT Progenity Option Alert: Jan 21 $2 Calls Sweep (13) near the Ask: 1679 @ $0.85 vs 10186 OI; Earnings 11/8 After Close [est] Ref=$2.13 Benzinga

12:17PM EDT Progenity Option Alert: Oct 15 $2 Calls Sweep (33) near the Ask: 471 @ $0.6 vs 21566 OI; Earnings 11/8 After Close [est] Ref=$2.12 Benzinga

11:14AM EDT Progenity Option Alert: Jan 21 $2.5 Calls Sweep (7) near the Ask: 466 @ $0.65 vs 28654 OI; Earnings 11/8 After Close [est] Ref=$1.94 Benzinga

Oct 1, 2021

06:05AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 5.45 A.M. EDT). RTTNews

Sep 30, 2021

11:22AM EDT Progenity's Return On Capital Employed Insights Benzinga

06:30AM EDT The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.15 A.M. EDT). RTTNews

Sep 21, 2021

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11thannual Partnership Opportunities in Drug Delivery(PODD) Conference, October 28-29, 2021 in Boston. GlobeNewswire Inc

Sep 14, 2021

08:56AM EDT Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Sept. 14, 2021: LEN, LICD, HLF, NNVC, PROG Benzinga

07:33AM EDT Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test Benzinga

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and dissociated placental growth factor. GlobeNewswire Inc

Sep 3, 2021

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in two upcoming virtual investor conferences: GlobeNewswire Inc

Aug 27, 2021

06:44AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 6.17 A.M. EDT). RTTNews

Aug 24, 2021

04:05PM EDT Progenity, Inc. (Progenity) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to 40,000,000 shares of its common stock, at a public offering price of $1.00 per share and associated warrant. GlobeNewswire Inc

Aug 20, 2021

02:42PM EDT Mid-Afternoon Market Update: Crude Oil Down Over 2%; GeoVax Labs Shares Spike Higher Benzinga

12:12PM EDT Mid-Day Market Update: Nasdaq Rises 1%; HEXO Shares Plummet Benzinga

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

06:03AM EDT Pre-market Movers: GOVX, PROG, SONN, MRIN, RTTNews

05:50AM EDT Progenity Shares Fall 45% Premarket After Company Priced 40M Share Offering @$1/Share and Accompanying Warrant Benzinga

Aug 19, 2021

10:21PM EDT Progenity Announces Pricing of $40 MillionPublic GlobeNewswire Inc

04:06PM EDT Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants Benzinga

04:05PM EDT Progenity Announces Proposed Underwritten Public Offering of GlobeNewswire Inc

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 12, 2021

04:40PM EDT Progenity Q2 EPS $(1.23) Misses $(0.80) Estimate Benzinga

04:01PM EDT Announced successful completion of the validation study PRO-104 for the Preecludiarule out test for preeclampsia and achievement of the primary endpoint of the study protocol GlobeNewswire Inc

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

04:14AM EDT Earnings Scheduled For August 12, 2021 Benzinga

Aug 11, 2021

08:14AM EDT The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering Benzinga

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Jul 30, 2021

04:11PM EDT Progenity Files For Mixed Shelf Of Up To $200M Benzinga

Jul 29, 2021

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today successful completion of the validation study for its Preecludia rule-out test for preeclampsia and achievement of the primary endpoint of the study protocol. GlobeNewswire Inc

Jun 30, 2021

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Surbhi Sarna to its board of directors effective July 1, 2021. Ms. Surbhis medical device experience and her focus on development of strategic partnerships will prove valuable as the company advances its innovation pipeline. GlobeNewswire Inc

Jun 25, 2021

10:50PM EDT Swick & Foti, LLC Continues to Investigate the Officers and Directors of Progenity, Inc. - PROG PR Newswire

Jun 17, 2021

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the formation of its Inflammatory Bowel Disease Clinical Advisory Board. The advisory board includes respected researchers and clinicians who are thought leaders in the research and treatment of inflammatory bowel disease (IBD). GlobeNewswire Inc

Jun 15, 2021

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that Harry Stylli, PhD, CEO, chairman of the board, and co-founder of Progenity, will participate in a fireside chat at the virtual Raymond James 2021 Human Health Innovation Conference at 10:40 a.m. ET / 7:40 a.m. PT on Tuesday, June 22, 2021. GlobeNewswire Inc

Jun 11, 2021

10:50PM EDT PROGENITY INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Progenity, Inc. - PROG Business Wire

Jun 10, 2021

07:40AM EDT Progenity Announces $40M Private Placement Benzinga

07:30AM EDT Progenity Announces $40 Million Private Placement GlobeNewswire Inc

Jun 4, 2021

09:39AM EDT The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact Benzinga

Jun 3, 2021

04:49PM EDT Progenity Shares Spike Higher; Co Reports NB Alternatives GP Holdings Buys 1,268,115 Shares At Average Price Of $2.86 Benzinga

10:09AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 Benzinga

07:47AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

07:10AM EDT Raymond James Downgrades Progenity to Market Perform Benzinga

06:47AM EDT Baird Downgrades Progenity to Neutral, Lowers Price Target to $2 Benzinga

Jun 2, 2021

12:24PM EDT Progenity to Close Genetic Test Services, Shifts Focus to Therapeutics Benzinga

12:15PM EDT Progenity to Close Genetic Test Services, Focus Shifts to Therapeutics Benzinga

07:13AM EDT Progenity To Focus On R&D Pipeline, Will Discontinue Providing Genetic Lab-Developed Test Services; Closure Of Genetics Lab To Result On ~70% Reduction Of Annual Capital Requirements Benzinga

07:00AM EDT Closure of genetics lab and other operational improvements expected to result in approximately 70% reduction of annual capital required for operations from more than $180 million currently to targeted operating expenses of ~$50 million in 2022 GlobeNewswire Inc

May 26, 2021

09:10AM EDT Progenity's Targeted Delivery Of Adalimumab Shows Encouraging Action In Animal Models Induced With Colitis Benzinga

07:41AM EDT Progenity Provides Results From Key Study For Its Targeted Therapeutics Program Benzinga

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced results from a further study for the companys Targeted Therapeutics program. The study evaluated delivery of Progenitys PGN-001 (adalimumab) drug substance directly to the colon in a preclinical model of colitis. GlobeNewswire Inc

May 25, 2021

07:30AM EDT Sean Lavin, MD, Joins Progenity as Vice President, Business GlobeNewswire Inc

May 24, 2021

07:30AM EDT Progenity Announces Poster Presentations at Digestive Disease Week GlobeNewswire Inc

May 21, 2021

07:30AM EDT Progenity Joins Global Call to Raise Awareness of Preeclampsia in GlobeNewswire Inc

May 20, 2021

08:27AM EDT The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks Benzinga

May 17, 2021

08:11AM EDT 10 Biggest Price Target Changes For Monday Benzinga

07:21AM EDT Wells Fargo Maintains Underweight on Progenity, Lowers Price Target to $2 Benzinga

May 14, 2021

07:40AM EDT Raymond James Maintains Outperform on Progenity, Lowers Price Target to $7 Benzinga

May 13, 2021

04:06PM EDT Progenity Q1 EPS $(0.56) May Not Compare To $(0.81) Estimate, Sales $24.50M Miss $25.40M Estimate Benzinga

04:03PM EDT Reports revenues of $24.5 million in the first quarter of 2021, up 72% from prior quarter GlobeNewswire Inc

04:15AM EDT Earnings Scheduled For May 13, 2021 Benzinga

May 12, 2021

07:30AM EDT Progenity Provides Preliminary Results From Key Studies For Its Targeted Therapeutics Program Benzinga

07:29AM EDT Progenity Provides Preliminary Results from Key Studies for its GlobeNewswire Inc

May 11, 2021

07:38AM EDT Progenity Receives Funding From Crohn's & Colitis Foundation IBD Ventures Fund To Develop Drug Delivery System For IBD; Amount Not Disclosed Benzinga

07:30AM EDT Progenity Receives Funding from Crohns & Colitis GlobeNewswire Inc

May 6, 2021

07:30AM EDT Progenity to Report First Quarter 2021 Financial Results and GlobeNewswire Inc

May 5, 2021

07:54AM EDT Progenity Provides Key Update Regarding Preecludia Test For Preeclampsia; Says Systems Demonstrated 'Commercial Readiness As Part Of A Pre-Validation Test' Benzinga

07:30AM EDT Progenity Provides Key Update Regarding its GlobeNewswire Inc

May 4, 2021

07:30AM EDT Progenity survey showsmore women know their babys fruit size than the key indicator of a common pregnancy complication GlobeNewswire Inc

Apr 30, 2021

04:05PM EDT Progenity Highlights Presentation Of Key Verification Study Data For Preecludia At 2021 American College Of Obstetricians And Gynecologists Annual Meeting Benzinga

04:04PM EDT Progenity Presents Key Verification Study Data for GlobeNewswire Inc

Apr 26, 2021

07:30AM EDT Progenity to Present Two Abstracts for Novel Ingestible Drug GlobeNewswire Inc

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 8, 2021

07:30AM EDT Progenity to Present Key Prospective Verification Study Data for GlobeNewswire Inc

Apr 6, 2021

09:44AM EDT Ionis Antisense Oligonucleotides To Be Evaluated With Progenity's Drug Delivery System Benzinga

07:36AM EDT Progenity And Ionis Pharmaceuticals Enter Agreement To Evaluate Progenity's Ingestible Oral Biotherapeutics Technology For Delivery Of Antisense Therapies Benzinga

07:30AM EDT Progenity and Ionis Pharmaceuticals Enter into Agreement to GlobeNewswire Inc

Mar 27, 2021

09:59AM EDT Johnson Fistel Investigates Progenity; Should Management be Held Accountable PR Newswire

Mar 19, 2021

10:42AM EDT Progenity shares were trading lower after the company reported worse-than-expected Q4 EPS results. Benzinga

Mar 18, 2021

04:06PM EDT Progenity Q4 EPS $(1.53) Misses $(0.82) Estimate, Sales $14.28M May Not Compare To $24.72M Estimate Benzinga

04:05PM EDT Progenity Provides Corporate Updates and Reports Fourth Quarter GlobeNewswire Inc

07:07AM EDT Earnings Scheduled For March 18, 2021 Benzinga

Mar 12, 2021

07:30AM EST Progenity to Report Fourth Quarter and Full Year 2020 Financial GlobeNewswire Inc

Feb 23, 2021

01:32PM EST Progenity Secures $25M Via Equity Issued At 5% Discount Benzinga

07:46AM EST Progenity Announces $25M Private Placement; 4,370,629 Shares At $5.72./Share Benzinga

07:45AM EST Progenity Announces $25 Million Private Placement GlobeNewswire Inc

Feb 19, 2021

12:26AM EST SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

Feb 17, 2021

07:32AM EST Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases Benzinga

07:30AM EST Progenity Initiates Safety and Tolerability Study of GlobeNewswire Inc

Feb 12, 2021

07:30AM EST SMFM Conference and Publications Highlight the Challenges and GlobeNewswire Inc

Feb 10, 2021

07:30AM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder of Progenity, is scheduled to participate in two upcoming virtual investor conferences: GlobeNewswire Inc

Feb 8, 2021

12:25PM EST Why Progenity's Stock Is Trading Lower Today Benzinga

10:12AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2021 Benzinga

09:35AM EST Wells Fargo Downgrades Progenity to Underweight, Lowers Price Target to $5 Benzinga

07:25AM EST Tonix Pharma Plans To Develop COVID-19 Skin Test To Measure SARS-CoV-2 Exposure And T Cell Immunity RTTNews

07:01AM EST PROG Holdings, Inc. Announces Fourth Quarter 2020 Earnings Call and Webcast PR Newswire

Jan 20, 2021

07:34AM EST Progenity Says Has Completed Two Million Diagnostic Tests Benzinga

07:30AM EST Progenity Reaches Two Million Test Milestone GlobeNewswire Inc

Jan 13, 2021

04:10PM EST Progenity Sees FY21 Core Molecular Testing Volume 290K-310K, SARS CoV-2 Volume 275K-300K Benzinga

04:09PM EST Progenity Sees FY21 Sales $130M-$145M vs $134.5M Estimate Benzinga

04:05PM EST Total 2021 revenue expected to grow by up to 30%1, reaching a range of $130 to $145 million GlobeNewswire Inc

Jan 5, 2021

07:30AM EST Progenity to Present at the 2021 ICR Conference GlobeNewswire Inc

Dec 17, 2020

07:31AM EST Progenity Says Expanding Availability Of COVID-19 RT-PCR Testing Across US Benzinga

07:30AM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products in womens health, today announced that it is expanding the availability of COVID-19 RT-PCR testing across the United States to support the rising demand for testing. GlobeNewswire Inc

Dec 8, 2020

07:31AM EST Progenity Announces Closing of the Convertible Senior Notes GlobeNewswire Inc

07:30AM EST Progenity Announces Closing of Public Offering of Common Stock GlobeNewswire Inc

Dec 3, 2020

12:17AM EST Progenity Prices Public Offering Of 7.65 Mln Shares At $3.27/Shr RTTNews

12:16AM EST Progenity Prices Offering Of $75 Mln Of 7.25% Convertible Senior Notes Due 2025 RTTNews

Dec 2, 2020

11:51PM EST Progenity, Inc. Prices $75.0 Million Convertible Senior Notes Offering GlobeNewswire Inc

11:51PM EST Progenity Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc

Nov 30, 2020

09:39PM EST Progenity Announces Proposed Convertible Senior Notes Offering GlobeNewswire Inc

09:39PM EST Progenity Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

Nov 20, 2020

07:32AM EST Progenity Reports Clinical Verification Data For Its Preecludia Preeclampsia Rule-Out Lab-Developed Test Currently In Development Benzinga

07:30AM EST New Test for Triaging Preeclampsia Passes Key Development GlobeNewswire Inc

Nov 18, 2020

05:09PM EST Progenity Says Approved Termination Of ~9.5% Of Workforce, About 67 Employees, Says Employees Impacted By Reduction In Force Will Exit Company In Q4 Of 2020 Benzinga

Nov 17, 2020

07:30AM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020. GlobeNewswire Inc

Nov 16, 2020

07:30AM EST Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder of Progenity, will participate in a fireside chat at the virtual Piper Sandler Healthcare Conference, being held December 1-3, 2020. GlobeNewswire Inc

Nov 13, 2020

09:29AM EST Progenity to Host Preeclampsia Virtual R&D Day on November 20, 2020 GlobeNewswire Inc

Nov 10, 2020

08:22AM EST Raymond James Maintains Outperform on Progenity, Lowers Price Target to $10 Benzinga

Nov 9, 2020

04:24PM EST Progenity Q3 EPS $(1.01) Misses $(0.72) Estimate, Sales $25.90M Miss $34.74M Estimate Benzinga

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 6, 2020

07:41AM EST Progenity PR Highlights Preclinical Data On Its Oral Drug Delivery System In Targeting The Colon Benzinga

07:30AM EST Progenity Announces Encouraging Preclinical Data Supporting the GlobeNewswire Inc

Nov 3, 2020

08:43AM EST Progenity to Report Third Quarter 2020 Financial Results and GlobeNewswire Inc

Oct 29, 2020

07:41AM EDT Progenity Announces Successful Achievement Of Its Preeclampsia Test Analytical Verification Milestone Benzinga

07:30AM EDT Progenity Announces Successful Achievement of its Preeclampsia GlobeNewswire Inc

Oct 27, 2020

07:51AM EDT Progenity Presents Data From Award-Winning Abstract On Novel Ingestible Lab-In-A-Capsule At American College Of Gastroenterology 2020 Virtual Annual Meeting Benzinga

07:30AM EDT Progenity Presents Data from Award-Winning Abstract on Novel GlobeNewswire Inc

Oct 23, 2020

12:09PM EDT BTIG Initiates Coverage On Progenity with Buy Rating, Announces Price Target of $12 Benzinga

11:00AM EDT PROG Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Progenity, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 27, 2020 Business Wire

Oct 21, 2020

10:00AM EDT BAK, FSLY & PROG Deadlines: Bronstein, Gewirtz & Grossman LLC GlobeNewswire Inc

Oct 20, 2020

05:00PM EDT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That GlobeNewswire Inc

11:01AM EDT Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG) PR Newswire

09:09AM EDT Only 7 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc. PR Newswire

Oct 19, 2020

12:18PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Oct 17, 2020

06:49PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

Oct 16, 2020

08:00PM EDT ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Progenity, Inc. GlobeNewswire Inc

12:00PM EDT Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class PR Newswire

Oct 15, 2020

01:00PM EDT BAK, FSLY & PROG Class Action Reminders: Bronstein, Gewirtz & GlobeNewswire Inc

11:30AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Oct 14, 2020

02:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

Oct 13, 2020

11:00AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

10:11AM EDT PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors GlobeNewswire Inc

09:03AM EDT announces that a securities class action lawsuit has been filed on behalf of shareholders OF Progenity, Inc. In the United States District Court for the SOUTHERN District of California PR Newswire

08:00AM EDT LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG, POR, AND GlobeNewswire Inc

Oct 12, 2020

09:57PM EDT Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (Progenity or the Company) (NASDAQ:PROG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

Oct 9, 2020

07:30AM EDT Progenity to Present Precision Medicine Abstracts at American GlobeNewswire Inc

Oct 7, 2020

04:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

12:30PM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

10:00AM EDT PROG Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

Oct 6, 2020

06:30PM EDT ROSEN, NATIONAL TRIAL LAWYERS, Reminds Progenity, Inc. Investors GlobeNewswire Inc

12:00PM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

08:00AM EDT LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG, POR, AND GlobeNewswire Inc

Oct 5, 2020

10:59PM EDT Investors of Important October 27 Deadline in Securities Class Action; Encourages Investors with Losses In Excess of $100K to Contact Firm - PROG PR Newswire

04:01PM EDT REMINDS INVESTORS THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF PROGENITY, INC. IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF CALIFORNIA PR Newswire

12:00PM EDT Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline GlobeNewswire Inc

Oct 3, 2020

10:25AM EDT (PROG) ALERT: Progenity Investors Reminded of Class Action Deadline; Investors PR Newswire

Oct 1, 2020

09:57AM EDT PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc. Business Wire

07:30AM EDT Progenity Supports the Preeclampsia Foundation Call to Action to GlobeNewswire Inc

Sep 30, 2020

11:14PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

05:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

11:30AM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Sep 29, 2020

11:45AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Sep 27, 2020

02:04AM EDT Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (Progenity or the Company) (NASDAQ:PROG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

Sep 25, 2020

06:45PM EDT ROSEN, TRUSTED AND LEADING INVESTOR CONSEL, Reminds Progenity, Inc GlobeNewswire Inc

11:30AM EDT Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline GlobeNewswire Inc

Sep 24, 2020

11:03AM EDT Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc. PR Newswire

11:00AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Sep 23, 2020

05:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

12:30PM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

08:00AM EDT LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG AND COTY: GlobeNewswire Inc

Sep 22, 2020

11:00AM EDT PROG Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GlobeNewswire Inc

Sep 21, 2020

08:38PM EDT Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (Progenity or the Company) (NASDAQ:PROG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

Sep 18, 2020

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will be added to the Russell2000 Index, effective when the U.S. market opens on Friday, September 18, 2020. GlobeNewswire Inc

Sep 17, 2020

11:15AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Sep 16, 2020

09:36PM EDT Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (Progenity or the Company) (NASDAQ:PROG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

06:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

12:30PM EDT Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Sep 15, 2020

02:37PM EDT PROGENITY, INC. (NASDAQ: PROG) INVESTOR NOTICE: Abraham, Fruchter GlobeNewswire Inc

10:06AM EDT PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors GlobeNewswire Inc

08:00AM EDT LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG AND COTY: GlobeNewswire Inc

Sep 14, 2020

08:30PM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

06:00PM EDT Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - PROG PR Newswire

Sep 10, 2020

03:49PM EDT ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF PROGENITY, INC. IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF CALIFORNIA PR Newswire

11:00AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

10:00AM EDT PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GlobeNewswire Inc

Sep 9, 2020

08:00PM EDT Bragar Eagel & Squire, P.C. Reminds Investors That Class Action GlobeNewswire Inc

03:19PM EDT The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class PR Newswire

Sep 8, 2020

08:30PM EDT Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Companys initial public offering conducted in June 2020 (the IPO). The lawsuit seeks to recover damages for Progenity investors under the federal securities laws. GlobeNewswire Inc

Sep 4, 2020

11:00AM EDT PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020 Business Wire

10:00AM EDT The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. GlobeNewswire Inc

Sep 3, 2020

10:00AM EDT PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GlobeNewswire Inc

09:00AM EDT If you own any of the above stocks and would like to discuss your legal rights, please emailleo@barrlaw.com or call (619) 400-4966. GlobeNewswire Inc

Sep 2, 2020

07:30AM EDT Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder of Progenity, is scheduled to participate in two upcoming virtual investor conferences: GlobeNewswire Inc

Sep 1, 2020

03:27PM EDT Progenity, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman GlobeNewswire Inc

01:45PM EDT Portnoy Law: Lawsuit Filed On Behalf of Progenity, Inc. Investors GlobeNewswire Inc

12:59PM EDT Gainey McKenna & Egleston Announces A Class Action Lawsuit Has GlobeNewswire Inc

Aug 31, 2020

02:52PM EDT PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Progenity, Inc. Business Wire

11:20AM EDT PROGENITY ALERT: Bragar Eagel & Squire, P.C. Announces That a GlobeNewswire Inc

10:00AM EDT Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020 PR Newswire

08:18AM EDT Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a securities class action has been filed against Progenity, Inc. (NASDAQ: PROG) and certain of its executives. Investors who purchased Progenity shares between and who lost money are encouraged to contact the firm for a free case evaluation. GlobeNewswire Inc

Aug 28, 2020

04:00PM EDT Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Progenity, Inc. (NASDAQ: PROG) on behalf of Progenity stockholders. Our investigation concerns whether Progenity has violated the federal securities laws and/or engaged in other unlawful business practices. GlobeNewswire Inc

Aug 25, 2020

05:44AM EDT Progenity Affiliate Avero Diagnostics Expands COVID-19 Testing Capabilities with Launch of Serology Testing Benzinga

Aug 21, 2020

07:30AM EDT Progenity Commends New Recommendations from ACOG and SMFM GlobeNewswire Inc

Aug 20, 2020

04:48PM EDT Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (Progenity or the Company) (NASDAQ:PROG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. GlobeNewswire Inc

Share